Codexis (NASDAQ: CDXS) insider files Rule 144 to sell 1,745 shares

Rhea-AI Filing Summary

Codexis executive Kevin Norrett filed a Rule 144 notice to sell 1,745 shares of Codexis common stock through Morgan Stanley Smith Barney LLC on or about 01/16/2026. The filing reports an aggregate market value of 2914.32 for these shares, with 90324383 common shares outstanding. The shares to be sold were acquired as restricted stock from the issuer on 01/01/2026, with 1,745 securities acquired on that date. The notice also discloses that during the past three months, Norrett sold 6115 and 8 common shares on 01/07/2026 for gross proceeds of 10376.08 and 13.72, respectively. By signing, the seller represents that he is not aware of any undisclosed material adverse information about Codexis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1745	2914.32	90324383	01/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2026	Restricted Stock	Issuer			1745	01/01/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Norrett 200 Penobscot Drive Redwood City CA 94063	Common	01/07/2026	6115	10376.08
Kevin Norrett 200 Penobscot Drive Redwood City CA 94063	Common	01/07/2026	8	13.72

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Codexis (CDXS) Rule 144 filing disclose?

The filing shows that Kevin Norrett has notified regulators of his intent to sell 1,745 Codexis common shares under Rule 144, using Morgan Stanley Smith Barney LLC as broker, with an approximate sale date of 01/16/2026.

How many Codexis shares is Kevin Norrett planning to sell?

The notice states that Kevin Norrett plans to sell 1,745 shares of Codexis common stock, with an aggregate market value reported as 2914.32.

How many Codexis shares are currently outstanding according to the filing?

The Rule 144 notice lists 90324383 Codexis common shares outstanding as the baseline share count.

What prior Codexis share sales by Kevin Norrett are reported in the last 3 months?

The document reports that on 01/07/2026, Kevin Norrett sold 6115 Codexis common shares for gross proceeds of 10376.08 and an additional 8 shares for 13.72.

How and when did Kevin Norrett acquire the Codexis shares he plans to sell?

The filing states that the 1,745 shares to be sold were acquired as restricted stock from the issuer on 01/01/2026, with payment described as Not Applicable.

Which exchange is referenced for the Codexis shares in this Rule 144 notice?

The filing names NASDAQ as the securities exchange for the Codexis common shares covered by this Rule 144 notice.

What representation does the seller make about Codexis in the Rule 144 notice?

By signing the notice, the seller represents that he does not know any material adverse information about Codexis’s current or prospective operations that has not been publicly disclosed.